Tirzepatide and investigational GLP-1 agents pemvidutide (by Altimmune), brenipatide and maxdutide (both by Eli Lilly) are also in Phase 2 trials for AUD
Archived from the original on 12 August 2025
While still investigational , the preliminary data are encouraging for those specializing in metabolic and cosmetic outcomes
Fatigue with dizziness, repeated vomiting, dehydration, low blood sugar symptoms, depression, chest symptoms, or severe weakness needs medical review
Before administering any compounded medication, we recommend performing the following due diligence: Verify the Prescriber: Is your prescription coming from a licensed medical provider (MD, DO, APRN, or PA) licensed to practice in Florida
1a, b,c